0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Pharmaceutical Contract Development and Manufacturing Market Research Report 2025
Published Date: August 2025
|
Report Code: QYRE-Auto-21Q9804
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Pharmaceutical Contract Development and Manufacturing Market Insights Forecast to 2028
BUY CHAPTERS

Global Pharmaceutical Contract Development and Manufacturing Market Research Report 2025

Code: QYRE-Auto-21Q9804
Report
August 2025
Pages:89
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Pharmaceutical Contract Development and Manufacturing Market Size

The global market for Pharmaceutical Contract Development and Manufacturing was valued at US$ 137600 million in the year 2024 and is projected to reach a revised size of US$ 211010 million by 2031, growing at a CAGR of 6.4% during the forecast period.

Pharmaceutical Contract Development and Manufacturing Market

Pharmaceutical Contract Development and Manufacturing Market

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report aims to provide a comprehensive presentation of the global market for Pharmaceutical Contract Development and Manufacturing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Pharmaceutical Contract Development and Manufacturing.
The Pharmaceutical Contract Development and Manufacturing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Pharmaceutical Contract Development and Manufacturing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Pharmaceutical Contract Development and Manufacturing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Pharmaceutical Contract Development and Manufacturing Market Report

Report Metric Details
Report Name Pharmaceutical Contract Development and Manufacturing Market
Accounted market size in year US$ 137600 million
Forecasted market size in 2031 US$ 211010 million
CAGR 6.4%
Base Year year
Forecasted years 2025 - 2031
Segment by Type
Segment by Application
  • Big Pharma
  • Small Pharma
  • Generic Pharma
  • CRO
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Thermo Fisher Scientific Inc., Catalent, Inc., Lonza Group Ltd, Recipharm AB, Vetter Pharma International GMBH, FAMAR Health Care Services, AbbVie Inc., Aenova Group, Consort Medical plc, Almac Group, Siegfried Holding AG, Boehringer Ingelheim International GmbH, Evonik Industries AG
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Pharmaceutical Contract Development and Manufacturing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Pharmaceutical Contract Development and Manufacturing Market growing?

Ans: The Pharmaceutical Contract Development and Manufacturing Market witnessing a CAGR of 6.4% during the forecast period 2025-2031.

What is the Pharmaceutical Contract Development and Manufacturing Market size in 2031?

Ans: The Pharmaceutical Contract Development and Manufacturing Market size in 2031 will be US$ 211010 million.

Who are the main players in the Pharmaceutical Contract Development and Manufacturing Market report?

Ans: The main players in the Pharmaceutical Contract Development and Manufacturing Market are Thermo Fisher Scientific Inc., Catalent, Inc., Lonza Group Ltd, Recipharm AB, Vetter Pharma International GMBH, FAMAR Health Care Services, AbbVie Inc., Aenova Group, Consort Medical plc, Almac Group, Siegfried Holding AG, Boehringer Ingelheim International GmbH, Evonik Industries AG

What are the Application segmentation covered in the Pharmaceutical Contract Development and Manufacturing Market report?

Ans: The Applications covered in the Pharmaceutical Contract Development and Manufacturing Market report are Big Pharma, Small Pharma, Generic Pharma, CRO

What are the Type segmentation covered in the Pharmaceutical Contract Development and Manufacturing Market report?

Ans: The Types covered in the Pharmaceutical Contract Development and Manufacturing Market report are Pharmaceutical Manufacturing Services, Biologics Manufacturing Services, Drug Development Services

Recommended Reports

Pharmaceutical Testing

Drug Development

Diagnostics & Monitoring

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Pharmaceutical Contract Development and Manufacturing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Pharmaceutical Manufacturing Services
1.2.3 Biologics Manufacturing Services
1.2.4 Drug Development Services
1.3 Market by Application
1.3.1 Global Pharmaceutical Contract Development and Manufacturing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Big Pharma
1.3.3 Small Pharma
1.3.4 Generic Pharma
1.3.5 CRO
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Pharmaceutical Contract Development and Manufacturing Market Perspective (2020-2031)
2.2 Global Pharmaceutical Contract Development and Manufacturing Growth Trends by Region
2.2.1 Global Pharmaceutical Contract Development and Manufacturing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Pharmaceutical Contract Development and Manufacturing Historic Market Size by Region (2020-2025)
2.2.3 Pharmaceutical Contract Development and Manufacturing Forecasted Market Size by Region (2026-2031)
2.3 Pharmaceutical Contract Development and Manufacturing Market Dynamics
2.3.1 Pharmaceutical Contract Development and Manufacturing Industry Trends
2.3.2 Pharmaceutical Contract Development and Manufacturing Market Drivers
2.3.3 Pharmaceutical Contract Development and Manufacturing Market Challenges
2.3.4 Pharmaceutical Contract Development and Manufacturing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Pharmaceutical Contract Development and Manufacturing Players by Revenue
3.1.1 Global Top Pharmaceutical Contract Development and Manufacturing Players by Revenue (2020-2025)
3.1.2 Global Pharmaceutical Contract Development and Manufacturing Revenue Market Share by Players (2020-2025)
3.2 Global Pharmaceutical Contract Development and Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Pharmaceutical Contract Development and Manufacturing Revenue
3.4 Global Pharmaceutical Contract Development and Manufacturing Market Concentration Ratio
3.4.1 Global Pharmaceutical Contract Development and Manufacturing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Pharmaceutical Contract Development and Manufacturing Revenue in 2024
3.5 Global Key Players of Pharmaceutical Contract Development and Manufacturing Head office and Area Served
3.6 Global Key Players of Pharmaceutical Contract Development and Manufacturing, Product and Application
3.7 Global Key Players of Pharmaceutical Contract Development and Manufacturing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Pharmaceutical Contract Development and Manufacturing Breakdown Data by Type
4.1 Global Pharmaceutical Contract Development and Manufacturing Historic Market Size by Type (2020-2025)
4.2 Global Pharmaceutical Contract Development and Manufacturing Forecasted Market Size by Type (2026-2031)
5 Pharmaceutical Contract Development and Manufacturing Breakdown Data by Application
5.1 Global Pharmaceutical Contract Development and Manufacturing Historic Market Size by Application (2020-2025)
5.2 Global Pharmaceutical Contract Development and Manufacturing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Pharmaceutical Contract Development and Manufacturing Market Size (2020-2031)
6.2 North America Pharmaceutical Contract Development and Manufacturing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Pharmaceutical Contract Development and Manufacturing Market Size by Country (2020-2025)
6.4 North America Pharmaceutical Contract Development and Manufacturing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Pharmaceutical Contract Development and Manufacturing Market Size (2020-2031)
7.2 Europe Pharmaceutical Contract Development and Manufacturing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Pharmaceutical Contract Development and Manufacturing Market Size by Country (2020-2025)
7.4 Europe Pharmaceutical Contract Development and Manufacturing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Pharmaceutical Contract Development and Manufacturing Market Size (2020-2031)
8.2 Asia-Pacific Pharmaceutical Contract Development and Manufacturing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Pharmaceutical Contract Development and Manufacturing Market Size by Region (2020-2025)
8.4 Asia-Pacific Pharmaceutical Contract Development and Manufacturing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Pharmaceutical Contract Development and Manufacturing Market Size (2020-2031)
9.2 Latin America Pharmaceutical Contract Development and Manufacturing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Pharmaceutical Contract Development and Manufacturing Market Size by Country (2020-2025)
9.4 Latin America Pharmaceutical Contract Development and Manufacturing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Pharmaceutical Contract Development and Manufacturing Market Size (2020-2031)
10.2 Middle East & Africa Pharmaceutical Contract Development and Manufacturing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Pharmaceutical Contract Development and Manufacturing Market Size by Country (2020-2025)
10.4 Middle East & Africa Pharmaceutical Contract Development and Manufacturing Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Thermo Fisher Scientific Inc.
11.1.1 Thermo Fisher Scientific Inc. Company Details
11.1.2 Thermo Fisher Scientific Inc. Business Overview
11.1.3 Thermo Fisher Scientific Inc. Pharmaceutical Contract Development and Manufacturing Introduction
11.1.4 Thermo Fisher Scientific Inc. Revenue in Pharmaceutical Contract Development and Manufacturing Business (2020-2025)
11.1.5 Thermo Fisher Scientific Inc. Recent Development
11.2 Catalent, Inc.
11.2.1 Catalent, Inc. Company Details
11.2.2 Catalent, Inc. Business Overview
11.2.3 Catalent, Inc. Pharmaceutical Contract Development and Manufacturing Introduction
11.2.4 Catalent, Inc. Revenue in Pharmaceutical Contract Development and Manufacturing Business (2020-2025)
11.2.5 Catalent, Inc. Recent Development
11.3 Lonza Group Ltd
11.3.1 Lonza Group Ltd Company Details
11.3.2 Lonza Group Ltd Business Overview
11.3.3 Lonza Group Ltd Pharmaceutical Contract Development and Manufacturing Introduction
11.3.4 Lonza Group Ltd Revenue in Pharmaceutical Contract Development and Manufacturing Business (2020-2025)
11.3.5 Lonza Group Ltd Recent Development
11.4 Recipharm AB
11.4.1 Recipharm AB Company Details
11.4.2 Recipharm AB Business Overview
11.4.3 Recipharm AB Pharmaceutical Contract Development and Manufacturing Introduction
11.4.4 Recipharm AB Revenue in Pharmaceutical Contract Development and Manufacturing Business (2020-2025)
11.4.5 Recipharm AB Recent Development
11.5 Vetter Pharma International GMBH
11.5.1 Vetter Pharma International GMBH Company Details
11.5.2 Vetter Pharma International GMBH Business Overview
11.5.3 Vetter Pharma International GMBH Pharmaceutical Contract Development and Manufacturing Introduction
11.5.4 Vetter Pharma International GMBH Revenue in Pharmaceutical Contract Development and Manufacturing Business (2020-2025)
11.5.5 Vetter Pharma International GMBH Recent Development
11.6 FAMAR Health Care Services
11.6.1 FAMAR Health Care Services Company Details
11.6.2 FAMAR Health Care Services Business Overview
11.6.3 FAMAR Health Care Services Pharmaceutical Contract Development and Manufacturing Introduction
11.6.4 FAMAR Health Care Services Revenue in Pharmaceutical Contract Development and Manufacturing Business (2020-2025)
11.6.5 FAMAR Health Care Services Recent Development
11.7 AbbVie Inc.
11.7.1 AbbVie Inc. Company Details
11.7.2 AbbVie Inc. Business Overview
11.7.3 AbbVie Inc. Pharmaceutical Contract Development and Manufacturing Introduction
11.7.4 AbbVie Inc. Revenue in Pharmaceutical Contract Development and Manufacturing Business (2020-2025)
11.7.5 AbbVie Inc. Recent Development
11.8 Aenova Group
11.8.1 Aenova Group Company Details
11.8.2 Aenova Group Business Overview
11.8.3 Aenova Group Pharmaceutical Contract Development and Manufacturing Introduction
11.8.4 Aenova Group Revenue in Pharmaceutical Contract Development and Manufacturing Business (2020-2025)
11.8.5 Aenova Group Recent Development
11.9 Consort Medical plc
11.9.1 Consort Medical plc Company Details
11.9.2 Consort Medical plc Business Overview
11.9.3 Consort Medical plc Pharmaceutical Contract Development and Manufacturing Introduction
11.9.4 Consort Medical plc Revenue in Pharmaceutical Contract Development and Manufacturing Business (2020-2025)
11.9.5 Consort Medical plc Recent Development
11.10 Almac Group
11.10.1 Almac Group Company Details
11.10.2 Almac Group Business Overview
11.10.3 Almac Group Pharmaceutical Contract Development and Manufacturing Introduction
11.10.4 Almac Group Revenue in Pharmaceutical Contract Development and Manufacturing Business (2020-2025)
11.10.5 Almac Group Recent Development
11.11 Siegfried Holding AG
11.11.1 Siegfried Holding AG Company Details
11.11.2 Siegfried Holding AG Business Overview
11.11.3 Siegfried Holding AG Pharmaceutical Contract Development and Manufacturing Introduction
11.11.4 Siegfried Holding AG Revenue in Pharmaceutical Contract Development and Manufacturing Business (2020-2025)
11.11.5 Siegfried Holding AG Recent Development
11.12 Boehringer Ingelheim International GmbH
11.12.1 Boehringer Ingelheim International GmbH Company Details
11.12.2 Boehringer Ingelheim International GmbH Business Overview
11.12.3 Boehringer Ingelheim International GmbH Pharmaceutical Contract Development and Manufacturing Introduction
11.12.4 Boehringer Ingelheim International GmbH Revenue in Pharmaceutical Contract Development and Manufacturing Business (2020-2025)
11.12.5 Boehringer Ingelheim International GmbH Recent Development
11.13 Evonik Industries AG
11.13.1 Evonik Industries AG Company Details
11.13.2 Evonik Industries AG Business Overview
11.13.3 Evonik Industries AG Pharmaceutical Contract Development and Manufacturing Introduction
11.13.4 Evonik Industries AG Revenue in Pharmaceutical Contract Development and Manufacturing Business (2020-2025)
11.13.5 Evonik Industries AG Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
 Table 1. Global Pharmaceutical Contract Development and Manufacturing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
 Table 2. Key Players of Pharmaceutical Manufacturing Services
 Table 3. Key Players of Biologics Manufacturing Services
 Table 4. Key Players of Drug Development Services
 Table 5. Global Pharmaceutical Contract Development and Manufacturing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
 Table 6. Global Pharmaceutical Contract Development and Manufacturing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 7. Global Pharmaceutical Contract Development and Manufacturing Market Size by Region (2020-2025) & (US$ Million)
 Table 8. Global Pharmaceutical Contract Development and Manufacturing Market Share by Region (2020-2025)
 Table 9. Global Pharmaceutical Contract Development and Manufacturing Forecasted Market Size by Region (2026-2031) & (US$ Million)
 Table 10. Global Pharmaceutical Contract Development and Manufacturing Market Share by Region (2026-2031)
 Table 11. Pharmaceutical Contract Development and Manufacturing Market Trends
 Table 12. Pharmaceutical Contract Development and Manufacturing Market Drivers
 Table 13. Pharmaceutical Contract Development and Manufacturing Market Challenges
 Table 14. Pharmaceutical Contract Development and Manufacturing Market Restraints
 Table 15. Global Pharmaceutical Contract Development and Manufacturing Revenue by Players (2020-2025) & (US$ Million)
 Table 16. Global Pharmaceutical Contract Development and Manufacturing Market Share by Players (2020-2025)
 Table 17. Global Top Pharmaceutical Contract Development and Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Contract Development and Manufacturing as of 2024)
 Table 18. Ranking of Global Top Pharmaceutical Contract Development and Manufacturing Companies by Revenue (US$ Million) in 2024
 Table 19. Global 5 Largest Players Market Share by Pharmaceutical Contract Development and Manufacturing Revenue (CR5 and HHI) & (2020-2025)
 Table 20. Global Key Players of Pharmaceutical Contract Development and Manufacturing, Headquarters and Area Served
 Table 21. Global Key Players of Pharmaceutical Contract Development and Manufacturing, Product and Application
 Table 22. Global Key Players of Pharmaceutical Contract Development and Manufacturing, Date of Enter into This Industry
 Table 23. Mergers & Acquisitions, Expansion Plans
 Table 24. Global Pharmaceutical Contract Development and Manufacturing Market Size by Type (2020-2025) & (US$ Million)
 Table 25. Global Pharmaceutical Contract Development and Manufacturing Revenue Market Share by Type (2020-2025)
 Table 26. Global Pharmaceutical Contract Development and Manufacturing Forecasted Market Size by Type (2026-2031) & (US$ Million)
 Table 27. Global Pharmaceutical Contract Development and Manufacturing Revenue Market Share by Type (2026-2031)
 Table 28. Global Pharmaceutical Contract Development and Manufacturing Market Size by Application (2020-2025) & (US$ Million)
 Table 29. Global Pharmaceutical Contract Development and Manufacturing Revenue Market Share by Application (2020-2025)
 Table 30. Global Pharmaceutical Contract Development and Manufacturing Forecasted Market Size by Application (2026-2031) & (US$ Million)
 Table 31. Global Pharmaceutical Contract Development and Manufacturing Revenue Market Share by Application (2026-2031)
 Table 32. North America Pharmaceutical Contract Development and Manufacturing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 33. North America Pharmaceutical Contract Development and Manufacturing Market Size by Country (2020-2025) & (US$ Million)
 Table 34. North America Pharmaceutical Contract Development and Manufacturing Market Size by Country (2026-2031) & (US$ Million)
 Table 35. Europe Pharmaceutical Contract Development and Manufacturing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 36. Europe Pharmaceutical Contract Development and Manufacturing Market Size by Country (2020-2025) & (US$ Million)
 Table 37. Europe Pharmaceutical Contract Development and Manufacturing Market Size by Country (2026-2031) & (US$ Million)
 Table 38. Asia-Pacific Pharmaceutical Contract Development and Manufacturing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
 Table 39. Asia-Pacific Pharmaceutical Contract Development and Manufacturing Market Size by Region (2020-2025) & (US$ Million)
 Table 40. Asia-Pacific Pharmaceutical Contract Development and Manufacturing Market Size by Region (2026-2031) & (US$ Million)
 Table 41. Latin America Pharmaceutical Contract Development and Manufacturing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 42. Latin America Pharmaceutical Contract Development and Manufacturing Market Size by Country (2020-2025) & (US$ Million)
 Table 43. Latin America Pharmaceutical Contract Development and Manufacturing Market Size by Country (2026-2031) & (US$ Million)
 Table 44. Middle East & Africa Pharmaceutical Contract Development and Manufacturing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
 Table 45. Middle East & Africa Pharmaceutical Contract Development and Manufacturing Market Size by Country (2020-2025) & (US$ Million)
 Table 46. Middle East & Africa Pharmaceutical Contract Development and Manufacturing Market Size by Country (2026-2031) & (US$ Million)
 Table 47. Thermo Fisher Scientific Inc. Company Details
 Table 48. Thermo Fisher Scientific Inc. Business Overview
 Table 49. Thermo Fisher Scientific Inc. Pharmaceutical Contract Development and Manufacturing Product
 Table 50. Thermo Fisher Scientific Inc. Revenue in Pharmaceutical Contract Development and Manufacturing Business (2020-2025) & (US$ Million)
 Table 51. Thermo Fisher Scientific Inc. Recent Development
 Table 52. Catalent, Inc. Company Details
 Table 53. Catalent, Inc. Business Overview
 Table 54. Catalent, Inc. Pharmaceutical Contract Development and Manufacturing Product
 Table 55. Catalent, Inc. Revenue in Pharmaceutical Contract Development and Manufacturing Business (2020-2025) & (US$ Million)
 Table 56. Catalent, Inc. Recent Development
 Table 57. Lonza Group Ltd Company Details
 Table 58. Lonza Group Ltd Business Overview
 Table 59. Lonza Group Ltd Pharmaceutical Contract Development and Manufacturing Product
 Table 60. Lonza Group Ltd Revenue in Pharmaceutical Contract Development and Manufacturing Business (2020-2025) & (US$ Million)
 Table 61. Lonza Group Ltd Recent Development
 Table 62. Recipharm AB Company Details
 Table 63. Recipharm AB Business Overview
 Table 64. Recipharm AB Pharmaceutical Contract Development and Manufacturing Product
 Table 65. Recipharm AB Revenue in Pharmaceutical Contract Development and Manufacturing Business (2020-2025) & (US$ Million)
 Table 66. Recipharm AB Recent Development
 Table 67. Vetter Pharma International GMBH Company Details
 Table 68. Vetter Pharma International GMBH Business Overview
 Table 69. Vetter Pharma International GMBH Pharmaceutical Contract Development and Manufacturing Product
 Table 70. Vetter Pharma International GMBH Revenue in Pharmaceutical Contract Development and Manufacturing Business (2020-2025) & (US$ Million)
 Table 71. Vetter Pharma International GMBH Recent Development
 Table 72. FAMAR Health Care Services Company Details
 Table 73. FAMAR Health Care Services Business Overview
 Table 74. FAMAR Health Care Services Pharmaceutical Contract Development and Manufacturing Product
 Table 75. FAMAR Health Care Services Revenue in Pharmaceutical Contract Development and Manufacturing Business (2020-2025) & (US$ Million)
 Table 76. FAMAR Health Care Services Recent Development
 Table 77. AbbVie Inc. Company Details
 Table 78. AbbVie Inc. Business Overview
 Table 79. AbbVie Inc. Pharmaceutical Contract Development and Manufacturing Product
 Table 80. AbbVie Inc. Revenue in Pharmaceutical Contract Development and Manufacturing Business (2020-2025) & (US$ Million)
 Table 81. AbbVie Inc. Recent Development
 Table 82. Aenova Group Company Details
 Table 83. Aenova Group Business Overview
 Table 84. Aenova Group Pharmaceutical Contract Development and Manufacturing Product
 Table 85. Aenova Group Revenue in Pharmaceutical Contract Development and Manufacturing Business (2020-2025) & (US$ Million)
 Table 86. Aenova Group Recent Development
 Table 87. Consort Medical plc Company Details
 Table 88. Consort Medical plc Business Overview
 Table 89. Consort Medical plc Pharmaceutical Contract Development and Manufacturing Product
 Table 90. Consort Medical plc Revenue in Pharmaceutical Contract Development and Manufacturing Business (2020-2025) & (US$ Million)
 Table 91. Consort Medical plc Recent Development
 Table 92. Almac Group Company Details
 Table 93. Almac Group Business Overview
 Table 94. Almac Group Pharmaceutical Contract Development and Manufacturing Product
 Table 95. Almac Group Revenue in Pharmaceutical Contract Development and Manufacturing Business (2020-2025) & (US$ Million)
 Table 96. Almac Group Recent Development
 Table 97. Siegfried Holding AG Company Details
 Table 98. Siegfried Holding AG Business Overview
 Table 99. Siegfried Holding AG Pharmaceutical Contract Development and Manufacturing Product
 Table 100. Siegfried Holding AG Revenue in Pharmaceutical Contract Development and Manufacturing Business (2020-2025) & (US$ Million)
 Table 101. Siegfried Holding AG Recent Development
 Table 102. Boehringer Ingelheim International GmbH Company Details
 Table 103. Boehringer Ingelheim International GmbH Business Overview
 Table 104. Boehringer Ingelheim International GmbH Pharmaceutical Contract Development and Manufacturing Product
 Table 105. Boehringer Ingelheim International GmbH Revenue in Pharmaceutical Contract Development and Manufacturing Business (2020-2025) & (US$ Million)
 Table 106. Boehringer Ingelheim International GmbH Recent Development
 Table 107. Evonik Industries AG Company Details
 Table 108. Evonik Industries AG Business Overview
 Table 109. Evonik Industries AG Pharmaceutical Contract Development and Manufacturing Product
 Table 110. Evonik Industries AG Revenue in Pharmaceutical Contract Development and Manufacturing Business (2020-2025) & (US$ Million)
 Table 111. Evonik Industries AG Recent Development
 Table 112. Research Programs/Design for This Report
 Table 113. Key Data Information from Secondary Sources
 Table 114. Key Data Information from Primary Sources
 Table 115. Authors List of This Report


List of Figures
 Figure 1. Pharmaceutical Contract Development and Manufacturing Picture
 Figure 2. Global Pharmaceutical Contract Development and Manufacturing Market Size Comparison by Type (2020-2031) & (US$ Million)
 Figure 3. Global Pharmaceutical Contract Development and Manufacturing Market Share by Type: 2024 VS 2031
 Figure 4. Pharmaceutical Manufacturing Services Features
 Figure 5. Biologics Manufacturing Services Features
 Figure 6. Drug Development Services Features
 Figure 7. Global Pharmaceutical Contract Development and Manufacturing Market Size by Application (2020-2031) & (US$ Million)
 Figure 8. Global Pharmaceutical Contract Development and Manufacturing Market Share by Application: 2024 VS 2031
 Figure 9. Big Pharma Case Studies
 Figure 10. Small Pharma Case Studies
 Figure 11. Generic Pharma Case Studies
 Figure 12. CRO Case Studies
 Figure 13. Pharmaceutical Contract Development and Manufacturing Report Years Considered
 Figure 14. Global Pharmaceutical Contract Development and Manufacturing Market Size (US$ Million), Year-over-Year: 2020-2031
 Figure 15. Global Pharmaceutical Contract Development and Manufacturing Market Size, (US$ Million), 2020 VS 2024 VS 2031
 Figure 16. Global Pharmaceutical Contract Development and Manufacturing Market Share by Region: 2024 VS 2031
 Figure 17. Global Pharmaceutical Contract Development and Manufacturing Market Share by Players in 2024
 Figure 18. Global Top Pharmaceutical Contract Development and Manufacturing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Pharmaceutical Contract Development and Manufacturing as of 2024)
 Figure 19. The Top 10 and 5 Players Market Share by Pharmaceutical Contract Development and Manufacturing Revenue in 2024
 Figure 20. North America Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 21. North America Pharmaceutical Contract Development and Manufacturing Market Share by Country (2020-2031)
 Figure 22. United States Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 23. Canada Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 24. Europe Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 25. Europe Pharmaceutical Contract Development and Manufacturing Market Share by Country (2020-2031)
 Figure 26. Germany Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 27. France Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 28. U.K. Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 29. Italy Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 30. Russia Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 31. Nordic Countries Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 32. Asia-Pacific Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 33. Asia-Pacific Pharmaceutical Contract Development and Manufacturing Market Share by Region (2020-2031)
 Figure 34. China Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 35. Japan Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 36. South Korea Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 37. Southeast Asia Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 38. India Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 39. Australia Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 40. Latin America Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 41. Latin America Pharmaceutical Contract Development and Manufacturing Market Share by Country (2020-2031)
 Figure 42. Mexico Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 43. Brazil Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 44. Middle East & Africa Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 45. Middle East & Africa Pharmaceutical Contract Development and Manufacturing Market Share by Country (2020-2031)
 Figure 46. Turkey Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 47. Saudi Arabia Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 48. UAE Pharmaceutical Contract Development and Manufacturing Market Size YoY Growth (2020-2031) & (US$ Million)
 Figure 49. Thermo Fisher Scientific Inc. Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2020-2025)
 Figure 50. Catalent, Inc. Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2020-2025)
 Figure 51. Lonza Group Ltd Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2020-2025)
 Figure 52. Recipharm AB Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2020-2025)
 Figure 53. Vetter Pharma International GMBH Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2020-2025)
 Figure 54. FAMAR Health Care Services Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2020-2025)
 Figure 55. AbbVie Inc. Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2020-2025)
 Figure 56. Aenova Group Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2020-2025)
 Figure 57. Consort Medical plc Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2020-2025)
 Figure 58. Almac Group Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2020-2025)
 Figure 59. Siegfried Holding AG Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2020-2025)
 Figure 60. Boehringer Ingelheim International GmbH Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2020-2025)
 Figure 61. Evonik Industries AG Revenue Growth Rate in Pharmaceutical Contract Development and Manufacturing Business (2020-2025)
 Figure 62. Bottom-up and Top-down Approaches for This Report
 Figure 63. Data Triangulation
 Figure 64. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String

RELATED REPORTS

Global Pharma and Healthcare Social Media Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-14Y6812
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Food Additives Testing Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-34O3983
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Gabapentin API Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-9V17601
Fri Sep 12 00:00:00 UTC 2025

Add to Cart

Global Electronic Informed Consent Market Research Report 2025

120 Pages
Type: Report
Code: QYRE-Auto-22C17047
Fri Sep 12 00:00:00 UTC 2025

Add to Cart